Alan Lewis: Embryonic Stem Cell Therapies for diabetes Medical Video by Endocrinology

Alan Lewis: Embryonic Stem Cell Therapies for diabetes

Endocrinology

Currently 0.00/5
1
2
3
4
5

Rating: 0.0 out of 0 votes

Comments (0)

You need to have the Flash Player installed and a browser with JavaScript support.

Description

Embryonic stem cells have the potential to help treat 70 or more diseases, but developing those new therapies will take time. Alan Lewis is president and CEO of Novocell, a La Jolla-based company that has been developing a potential therapy for diabetes. Novocell has a CIRM grant to assemble a team of researchers who will accelerate the time it takes to get that potential therapy to the FDA for clinical trials.